You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RRMM

Showing 151 - 174 of 174
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Multiple Myeloma Trial in Boston, New York, Charlotte (NMS-03597812, NMS-03597812 + dexamethasone)

Not yet recruiting
  • Multiple Myeloma
  • Boston, Massachusetts
  • +2 more
Aug 25, 2021

Multiple Myeloma Trial in France, United States (M3258, Dexamethasone)

Terminated
  • Multiple Myeloma
  • Denver, Colorado
  • +6 more
May 10, 2021

Multiple Myeloma Trial in Worldwide (DARATUMUMAB, DURVALUMAB)

Completed
Has Results
  • Multiple Myeloma
  • Duarte, California
  • +24 more
Sep 18, 2018

Multiple Myeloma Trial in Worldwide (Modakafusp Alfa, Daratumumab)

Recruiting
  • Multiple Myeloma
  • Gilbert, Arizona
  • +40 more
Jan 23, 2023

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Houston (Dexamethasone, Lenalidomide, Thalidomide)

Completed
Has Results
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Houston, Texas
    M D Anderson Cancer Center
Oct 12, 2020

Relapsed, Refractory, Multiple Myeloma Trial in Guangzhou (Pomalidomide, Bendamustine, Dexamethasone)

Not yet recruiting
  • Relapsed, Refractory, Multiple Myeloma
  • Guangzhou, Please Select, China
    Sun Yat-sen University Cancer Center
Feb 17, 2021

Multiple Myeloma, Multiple Myeloma in Relapse, Tumors Trial (Belantamab Mafodotin-Blmf, Daratumumab, Pomalidomide)

Not yet recruiting
  • Multiple Myeloma
  • +8 more
  • Belantamab Mafodotin-Blmf
  • +3 more
  • (no location specified)
Oct 13, 2022

Multiple Myeloma Trial in Worldwide (Cyclophosphamide, Ixazomib, Dexamethasone)

Completed
Has Results
  • Multiple Myeloma
  • Hazard, Kentucky
  • +23 more
Jun 24, 2019

Relapsed and/or Refractory Multiple Myeloma Trial in Japan (Ixazomib, Lenalidomide, Dexamethasone)

Completed
Has Results
  • Relapsed and/or Refractory Multiple Myeloma
  • Nagoya, Aichi, Japan
  • +20 more
Dec 18, 2020

Multiple Myeloma Trial in Bengbu, Zhengzhou, Shanghai (FHND6091)

Recruiting
  • Multiple Myeloma
  • Bengbu, Anhui, China
  • +2 more
May 10, 2022

Multiple Myeloma Trial in Belgium, France (Daratumumab, Dexamethasone)

Completed
  • Multiple Myeloma
  • Bruges, Belgium
  • +40 more
Mar 25, 2021

Quality of Life, Symptoms and Treatment Satisfaction in Adult

Unknown status
  • Relapsed and/or Refractory Multiple Myeloma
  • ixazomib in combination with lenalidomide and dexamethasone
  • (no location specified)
Apr 2, 2019

Multiple Myeloma Trial in China (Daratumumab)

Completed
  • Multiple Myeloma
  • Beijing, China
  • +4 more
Nov 12, 2020

Relapsed Multiple Myeloma, Refractory Multiple Myeloma Trial in Worldwide (Dexamethasone, Daratumumab, Carfilzomib)

Completed
Has Results
  • Relapsed Multiple Myeloma
  • Refractory Multiple Myeloma
  • Boca Raton, Florida
  • +112 more
Sep 9, 2022

CTFEA Myeloma Study

Not yet recruiting
  • Myeloma Multiple
  • Metastatic Bone Tumor
  • CT-based finite element analysis
  • (no location specified)
Apr 23, 2020

Multiple Myeloma, Advanced Solid Tumors Trial in Canada, United States (Ixazomib)

Completed
Has Results
  • Multiple Myeloma
  • Advanced Solid Tumors
  • Atlanta, Georgia
  • +10 more
Mar 8, 2019

Multiple Myeloma Symptomatic Relapse and/or Refractory Disease

Completed
Has Results
  • Multiple Myeloma
  • No Intervention
  • Cadiz, Andalucia, Spain
  • +29 more
Sep 14, 2020

Multiple Myeloma in Relapse Trial in Changchun (Clarithromycin Lenalidomide Dexamethasone (BiRd) Regimen)

Unknown status
  • Multiple Myeloma in Relapse
  • Clarithromycin Lenalidomide Dexamethasone (BiRd) Regimen
  • Changchun, Jilin, China
    The First Hospital of Jilin University
Aug 17, 2019

Multiple Myeloma in Relapse, Multiple Myeloma Progression, Refractory Multiple Myeloma Trial in Ciudad de Mexico (Pomalidomide)

Unknown status
  • Multiple Myeloma in Relapse
  • +2 more
  • Ciudad de Mexico, Mexico
    ISSSTE
Nov 13, 2018

Multiple Myeloma Trial in New York (Palbociclib, Dexamethasone, Lenalidomide)

Terminated
  • Multiple Myeloma
  • New York, New York
    Weill Cornell Medical College
Aug 21, 2018

Multiple Myeloma Trial in New York (VLX1570 and dexamethasone)

Terminated
  • Multiple Myeloma
  • VLX1570 and dexamethasone
  • New York, New York
    Memorial Sloan Kettering Cancer Center
May 3, 2018

LEn/Dex in Greek R/R Multiple MyEloma and Treatment PatterNs

Completed
  • Relapsed/Refractory Multiple Myeloma
    • Patra, Greece
      Patra
    May 18, 2018

    Multiple Myeloma Trial in United States (Ixazomib citrate)

    Completed
    Has Results
    • Multiple Myeloma
    • Ixazomib citrate
    • Scottsdale, Arizona
    • +5 more
    Dec 12, 2017

    Multiple Myeloma Trial in United States (Anti-KIR (1-7F9))

    Completed
    Has Results
    • Multiple Myeloma
    • Anti-KIR (1-7F9)
    • Indianapolis, Indiana
    • +3 more
    Mar 3, 2016